These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

154 related articles for article (PubMed ID: 37273034)

  • 1. Characteristics of the phenotype of mixed cardiomyopathy in patients with implantable cardioverter-defibrillators.
    Raja DC; Samarawickrema I; Menon SK; Singh R; Mehta A; Tuan LQ; Pandurangi U; Jain S; Callans DJ; Marchlinski FE; Abhayaratna WP; Sanders P; Pathak RK
    J Interv Card Electrophysiol; 2024 Jan; 67(1):129-137. PubMed ID: 37273034
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Implantable cardioverter defibrillator therapy in patients with ischemic or non-ischemic cardiomyopathy and nonsustained ventricular tachycardia.
    Evonich RF; Maheshwari A; Gardiner JC; Khasnis A; Kantipudi S; Ip JH; Grimes D; Hayter G; Thakur RK
    J Interv Card Electrophysiol; 2004 Aug; 11(1):59-65. PubMed ID: 15273456
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Adding the implantable cardioverter-defibrillator to cardiac resynchronization therapy is associated with improved long-term survival in ischaemic, but not in non-ischaemic cardiomyopathy.
    Witt CT; Kronborg MB; Nohr EA; Mortensen PT; Gerdes C; Jensen HK; Nielsen JC
    Europace; 2016 Mar; 18(3):413-9. PubMed ID: 26378089
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Comparison of Mortality and Readmission in Non-Ischemic Versus Ischemic Cardiomyopathy After Implantable Cardioverter-Defibrillator Implantation.
    Higgins AY; Bjerre J; Parzynski CS; Minges KE; Ahmad T; Desai NR; Enriquez A; Spatz ES; Friedman DJ; Curtis JP; Hlatky MA; Freeman JV
    Am J Cardiol; 2020 Oct; 133():116-125. PubMed ID: 32862971
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Association between mortality and implantable cardioverter-defibrillators by aetiology of heart failure: a propensity-matched analysis of the WARCEF trial.
    Lee TC; Qian M; Mu L; Di Tullio MR; Graham S; Mann DL; Nakanishi K; Teerlink JR; Lip GYH; Freudenberger RS; Sacco RL; Mohr JP; Labovitz AJ; Ponikowski P; Lok DJ; Estol C; Anker SD; Pullicino PM; Buchsbaum R; Levin B; Thompson JLP; Homma S; Ye S;
    ESC Heart Fail; 2019 Apr; 6(2):297-307. PubMed ID: 30816013
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Survival and arrhythmic risk among ischemic and non-ischemic heart failure patients with prophylactic implantable cardioverter defibrillator only therapy: A propensity score-matched analysis.
    Briongos-Figuero S; Estévez A; Luisa Pérez M; Martínez-Ferrer JB; García E; Viñolas X; Arenal Á; Alzueta J; Basterra N; Rodríguez A; Lozano I; Muñoz-Aguilera R
    Int J Cardiol; 2019 Jan; 274():163-169. PubMed ID: 30206014
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Comparison of ventricular tachyarrhythmia characteristics in patients with idiopathic dilated or ischemic cardiomyopathy and defibrillators implanted for primary prevention.
    Streitner F; Kuschyk J; Dietrich C; Mahl E; Streitner I; Doesch C; Veltmann C; Schimpf R; Wolpert C; Borggrefe M
    Clin Cardiol; 2011 Oct; 34(10):604-9. PubMed ID: 21887690
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Long-term outcomes after prophylactic ICD and CRT-D implantation in nonischemic patients: Analysis from a nationwide database of daily remote-monitoring transmissions.
    Forleo GB; Solimene F; Pisanò EC; Zanotto G; Calvi V; Pignalberi C; Maglia G; Iacopino S; Quartieri F; Biffi M; Caravati F; Curnis A; Capucci A; Senatore G; Santamaria M; Della Bella P; Manzo M; Giacopelli D; Gargaro A; D'Onofrio A
    J Cardiovasc Electrophysiol; 2019 Sep; 30(9):1626-1635. PubMed ID: 31165517
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Characteristics of ventricular tachyarrhythmias and their susceptibility to antitachycardia pacing termination in patients with ischemic and nonischemic cardiomyopathy: A patient-level meta-analysis of three large clinical trials.
    Cheng A; Joung B; Brown ML; Koehler J; Lexcen DR; Sanders P; Ellenbogen KA
    J Cardiovasc Electrophysiol; 2020 Oct; 31(10):2720-2726. PubMed ID: 32700390
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Two-Year Outcomes of Primary Prophylactic Use of Defibrillators for Ischemic and Non-Ischemic Cardiomyopathy　- Propensity Score-Matched Analysis From the Nippon Storm Study.
    Kondo Y; Noda T; Takanashi Y; Sasaki S; Sato Y; Nitta T; Aizwa Y; Ohe T; Kurita T
    Circ J; 2024 Jun; 88(7):1107-1114. PubMed ID: 38057099
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Implantable cardioverter-defibrillator therapy among patients with non-ischaemic vs. ischaemic cardiomyopathy for primary prevention of sudden cardiac death.
    Amara N; Boveda S; Defaye P; Klug D; Treguer F; Amet D; Perier MC; Gras D; Algalarrondo V; Bouzeman A; Piot O; Deharo JC; Fauchier L; Babuty D; Bordachar P; Sadoul N; Marijon E; Leclercq C;
    Europace; 2018 Jan; 20(1):65-72. PubMed ID: 28082419
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Therapy optimization in patients with heart failure: the role of the wearable cardioverter-defibrillator in a real-world setting.
    Röger S; Rosenkaimer SL; Hohneck A; Lang S; El-Battrawy I; Rudic B; Tülümen E; Stach K; Kuschyk J; Akin I; Borggrefe M
    BMC Cardiovasc Disord; 2018 Mar; 18(1):52. PubMed ID: 29544442
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Cardiovascular Magnetic Resonance to Predict Appropriate Implantable Cardioverter Defibrillator Therapy in Ischemic and Nonischemic Cardiomyopathy Patients Using Late Gadolinium Enhancement Border Zone: Comparison of Four Analysis Methods.
    Jablonowski R; Chaudhry U; van der Pals J; Engblom H; Arheden H; Heiberg E; Wu KC; Borgquist R; Carlsson M
    Circ Cardiovasc Imaging; 2017 Sep; 10(9):. PubMed ID: 28838961
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Cardioverter-defibrillator reduces mortality risk in eligible ischemic and non-ischemic cardiomyopathy patients: Sub-analysis of the multi-center Improve SCA study.
    Singh B; Hsieh YC; Liu YB; Lin KH; Joung B; Rodriguez DA; Chasnoits AR; Huang D; Zhang S; O'Brien JE; Lexcen DR; Cerkvenik J; Van Dorn B; Ching CK
    Indian Heart J; 2023; 75(2):115-121. PubMed ID: 36736459
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The Association of Clustered Ventricular Arrhythmia and Cycle Length With Scar Burden in Cardiomyopathy.
    Vakil RM; Marine JE; Kolandaivelu A; Dickfeld T; Weiss RG; Tomaselli GF; Chrispin J; Wu KC
    JACC Clin Electrophysiol; 2022 Aug; 8(8):957-966. PubMed ID: 35981800
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Arrhythmic and Mortality Outcomes Among Ischemic Versus Nonischemic Cardiomyopathy Patients Receiving Primary ICD Therapy.
    Narins CR; Aktas MK; Chen AY; McNitt S; Ling FS; Younis A; Zareba W; Daubert JP; Huang DT; Rosero S; Kutyifa V; Goldenberg I
    JACC Clin Electrophysiol; 2022 Jan; 8(1):1-11. PubMed ID: 34454875
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Impact of shocks on mortality in patients with ischemic or dilated cardiomyopathy and defibrillators implanted for primary prevention.
    Streitner F; Herrmann T; Kuschyk J; Lang S; Doesch C; Papavassiliu T; Streitner I; Veltmann C; Haghi D; Borggrefe M
    PLoS One; 2013; 8(5):e63911. PubMed ID: 23675514
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Differences in mode of death between men and women receiving implantable cardioverter-defibrillators or cardiac resynchronization therapy in the MADIT trials.
    Tompkins CM; Zareba W; Greenberg H; Goldstein R; McNitt S; Polonsky B; Brown M; Kutyifa V
    Heart Rhythm; 2023 Jan; 20(1):39-45. PubMed ID: 36007729
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Impact of T wave amplitude in lead aVR on predicting cardiac events in ischemic and nonischemic cardiomyopathy patients with an implantable cardioverter defibrillator.
    Tanaka Y; Konno T; Tamura Y; Tsuda T; Furusho H; Takamura M; Sakata K; Yamagishi M; Hayashi K
    Ann Noninvasive Electrocardiol; 2017 Nov; 22(6):. PubMed ID: 28440568
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Analysis of Outcomes in Ischemic vs Nonischemic Cardiomyopathy in Patients With Atrial Fibrillation: A Report From the GARFIELD-AF Registry.
    Corbalan R; Bassand JP; Illingworth L; Ambrosio G; Camm AJ; Fitzmaurice DA; Fox KAA; Goldhaber SZ; Goto S; Haas S; Kayani G; Mantovani LG; Misselwitz F; Pieper KS; Turpie AGG; Verheugt FWA; Kakkar AK;
    JAMA Cardiol; 2019 Jun; 4(6):526-548. PubMed ID: 31066873
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.